D-0612-2017 Class II Terminated

Recalled by Fougera Pharmaceuticals Inc. — Melville, NY

FDA drug recall D-0612-2017 was initiated by Fougera Pharmaceuticals Inc. on March 2, 2017 and is designated Class II. Reason for recall: Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream The recall status is terminated (terminated July 2, 2018). Affected quantity: 14,665 tubes.

Recall Details

Product Type
Drugs
Report Date
March 29, 2017
Initiation Date
March 2, 2017
Termination Date
July 2, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14,665 tubes

Product Description

Desonide Ointment, 0.05%, NET WT 60 grams tubes, Rx only, E. FOUGERA & CO. A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0309-60

Reason for Recall

Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream

Distribution Pattern

Nationwide

Code Information

Lot GC9231 (exp. 05/2019); Lot GC9232 (exp. 05/2019)